Publications
5803 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#6044
- Year
- 2007
- Research Committee(s)
- Head and Neck
- Study Number(s)
- S0420
A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). a Southwest Oncology Group (SWOG) trial.
- Journal / Conference
- Proc of the American Society of Clinical Oncology, Journal of Clinical Oncology 25(18S):#4639
- Year
- 2007
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0514
SWOG 0514: a phase II study of sorafenib (BAY 43-9006) as single agent in patients (pts) with unresectable or metastatic gallbladder cancer or cholangiocarcinomas
- Journal / Conference
- International Journal of Gynecological Cancer 17:784-788
- Year
- 2007
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0211
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211) [PMID17343607]
- Journal / Conference
- Journal of Thoracic Oncology 2(6):494-498
- Year
- 2007
- Research Committee(s)
- Lung
- Study Number(s)
- S0027
Chemotherapy in patients >80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6 [PMID17545843]
- Journal / Conference
- Journal of Thoracic Oncology 2(6):526-530
- Year
- 2007
- Research Committee(s)
- Lung
- Study Number(s)
- S0119
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119 [PMID17545848]
- Journal / Conference
- Journal of Clinical Oncology 25(17):2406-2413
- Year
- 2007
- Research Committee(s)
- Lung
- Study Number(s)
- S0218
A phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group study [PMID17557954]
- Journal / Conference
- Journal of Clinical Oncology 25(16):2225-2229
- Year
- 2007
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 [PMID17538167]
- Journal / Conference
- Journal of Urology 178(5):1946-1951
- Year
- 2007
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889), S9916
Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916 [PMID17868721]
- Journal / Conference
- Journal of the National Cancer Institute 99:1375-1383
- Year
- 2007
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217